FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

126097006: Ethinylestradiol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2153823018 Ethinylestradiol en Synonym Active Entire term case insensitive SNOMED CT core module
2154830016 Ethinyl estradiol en Synonym Active Entire term case insensitive SNOMED CT core module
3482238011 Ethinylestradiol (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ethinylestradiol Is a Norsteroid true Inferred relationship Existential restriction modifier
Ethinylestradiol Is a Estrogen false Inferred relationship Existential restriction modifier
Ethinylestradiol Is a Synthetic steroid false Inferred relationship Existential restriction modifier
Ethinylestradiol Is a Combination oral contraceptive agent false Inferred relationship Existential restriction modifier
Ethinylestradiol Is a Estradiol false Inferred relationship Existential restriction modifier
Ethinylestradiol Is a Oral contraceptive agent false Inferred relationship Existential restriction modifier
Ethinylestradiol Has disposition Estrogen false Inferred relationship Existential restriction modifier
Ethinylestradiol Is a Estrane false Inferred relationship Existential restriction modifier
Ethinylestradiol Is modification of Estradiol false Inferred relationship Existential restriction modifier
Ethinylestradiol Is a Estradiol and/or estradiol derivative true Inferred relationship Existential restriction modifier
Ethinylestradiol Has disposition Gonadal hormone false Inferred relationship Existential restriction modifier
Ethinylestradiol Is a Substance with estrogen receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Ethinylestradiol Has disposition Estrogen receptor agonist true Inferred relationship Existential restriction modifier
Ethinylestradiol Is a Steroid hormone true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bimizza 150microgram/20microgram tablets (Morningside Healthcare Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Bimizza 150microgram/20microgram tablets (Morningside Healthcare Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Yacella 0.03mg/3mg tablets (Morningside Healthcare Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Yacella 0.03mg/3mg tablets (Morningside Healthcare Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Bimizza 150microgram/20microgram tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Yacella 0.03mg/3mg tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Mawdsley-Brooks & Company Ltd) 63 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
ELOINE 0.02mg/3mg tablets (Bayer Plc) Has active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
ELOINE 0.02mg/3mg tablets (Bayer Plc) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
ELOINE 0.02mg/3mg tablets (Bayer Plc) 84 tablet 3 x 28 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Femodette tablets (Waymade Healthcare Plc) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Femodette tablets (Waymade Healthcare Plc) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Femodette tablets (Waymade Healthcare Plc) 63 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Daylette 0.02mg/3mg tablets (Consilient Health Ltd) 84 tablet 3 x 28 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (AM Distributions (Yorkshire) Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (AM Distributions (Yorkshire) Ltd) Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (AM Distributions (Yorkshire) Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Juliperla 75microgram / 20microgram tablets (Actavis UK Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Juliperla 75microgram / 20microgram tablets (Actavis UK Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Sofiperla 75microgram / 30microgram tablets (Actavis UK Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Sofiperla 75microgram / 30microgram tablets (Actavis UK Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Juliperla 75microgram / 20microgram tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Sofiperla 75microgram / 30microgram tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (DE Pharmaceuticals) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (DE Pharmaceuticals) Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (DE Pharmaceuticals) 63 tablet 3 x 21 tablets Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets (DE Pharmaceuticals) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets (DE Pharmaceuticals) Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (DE Pharmaceuticals) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (DE Pharmaceuticals) Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets (DE Pharmaceuticals) 63 tablet 3 x 21 tablets Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 20microgram / Desogestrel 150microgram tablets (DE Pharmaceuticals) 63 tablet 3 x 21 Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Cilique 250microgram/35microgram tablets (Gedeon Richter (UK) Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Cilique 250microgram/35microgram tablets (Gedeon Richter (UK) Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Cilique 250microgram/35microgram tablets (Gedeon Richter (UK) Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system (Ennogen Healthcare Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system (Ennogen Healthcare Ltd) Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system (Ennogen Healthcare Ltd) 3 system Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Desogestrel 150microgram tablets (Ennogen Healthcare Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Ennogen Healthcare Ltd) 63 tablet Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Colorama Pharmaceuticals Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Colorama Pharmaceuticals Ltd) Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (Colorama Pharmaceuticals Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Yiznell 0.03mg/3mg tablets (Lupin (Europe) Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Yiznell 0.03mg/3mg tablets (Lupin (Europe) Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Yiznell 0.03mg/3mg tablets (Lupin (Europe) Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Leandra 30microgram/150microgram tablets (Genesis Pharmaceuticals Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Leandra 30microgram/150microgram tablets (Genesis Pharmaceuticals Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Leandra 30microgram/150microgram tablets (Genesis Pharmaceuticals Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Drospirenone 3mg tablets 21 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Ellanite 0.03mg/3mg tablets (Kent Pharma (UK) Ltd) 21 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Norethisterone 1mg / Ethinylestradiol 35microgram tablets (Janssen-Cilag Ltd) 21 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Norethisterone 1mg / Ethinylestradiol 35microgram tablets 63 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Norethisterone 1mg / Ethinylestradiol 35microgram tablets 9 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Norethisterone 1mg / Ethinylestradiol 35microgram tablets (Pfizer Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Norethisterone 1mg / Ethinylestradiol 35microgram tablets (Pfizer Ltd) 9 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Norethisterone 1mg / Ethinylestradiol 35microgram tablets 21 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Norethisterone 1mg / Ethinylestradiol 35microgram tablets (Janssen-Cilag Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Norethisterone 1mg / Ethinylestradiol 35microgram tablets (Janssen-Cilag Ltd) 42 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Norimin 1mg/35microgram tablets (Pfizer Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Norimin 1mg/35microgram tablets (Pfizer Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Norethisterone 1mg / Ethinylestradiol 35microgram tablets 42 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol + Norethisterone acetate Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Generic Femodene ED tablets Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Generic Femodene ED tablets Has active ingredient False Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol + Norethisterone acetate Has active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 20microgram / Gestodene 75microgram tablets 21 tablet Has basis of strength substance True Ethinylestradiol Inferred relationship Existential restriction modifier 2
Ethinylestradiol 20microgram / Gestodene 75microgram tablets 21 tablet Has precise active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier 2
Ethinylestradiol 20microgram / Gestodene 75microgram tablets 21 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Ethinylestradiol 30microgram / Gestodene 75microgram tablets 21 tablet Has basis of strength substance True Ethinylestradiol Inferred relationship Existential restriction modifier 2
Ethinylestradiol 30microgram / Gestodene 75microgram tablets 21 tablet Has precise active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier 2
Ethinylestradiol 30microgram / Gestodene 75microgram tablets 21 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Katya 30/75 tablets (Kent Pharma (UK) Ltd) 21 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
Sunya 20/75 tablets (Kent Pharma (UK) Ltd) 21 tablet Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) Has active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Has specific active ingredient True Ethinylestradiol Inferred relationship Existential restriction modifier

Start Previous Page 13 of 13

This concept is not in any reference sets

Back to Start